Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Illumina Inc (ILMN)

Illumina Inc (ILMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,676,898
  • Shares Outstanding, K 152,800
  • Annual Sales, $ 4,372 M
  • Annual Income, $ -1,223 M
  • EBIT $ 782 M
  • EBITDA $ 1,136 M
  • 60-Month Beta 1.44
  • Price/Sales 4.76
  • Price/Cash Flow 29.03
  • Price/Book 8.74

Options Overview Details

View History
  • Implied Volatility 42.56% (+0.62%)
  • Historical Volatility 26.93%
  • IV Percentile 30%
  • IV Rank 16.09%
  • IV High 84.13% on 04/08/25
  • IV Low 34.59% on 11/14/25
  • Expected Move (DTE 21) 9.10 (6.74%)
  • Put/Call Vol Ratio 0.47
  • Today's Volume 1,357
  • Volume Avg (30-Day) 1,206
  • Put/Call OI Ratio 0.31
  • Today's Open Interest 47,502
  • Open Int (30-Day) 73,529
  • Expected Range 125.86 to 144.05

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.22
  • Number of Estimates 6
  • High Estimate 1.30
  • Low Estimate 1.18
  • Prior Year 0.86
  • Growth Rate Est. (year over year) +41.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
124.27 +8.59%
on 12/04/25
138.80 -2.77%
on 12/22/25
+5.14 (+3.96%)
since 11/26/25
3-Month
88.00 +53.35%
on 10/14/25
138.80 -2.77%
on 12/22/25
+43.26 (+47.18%)
since 09/26/25
52-Week
68.70 +96.43%
on 04/09/25
153.06 -11.83%
on 01/14/25
-0.01 (-0.01%)
since 12/26/24

Most Recent Stories

More News
Illumina To Webcast Upcoming Investor Conference

SAN DIEGO , Dec. 16, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that members of its management team will participate at the following investor conference:

ILMN : 134.95 (-0.27%)
Illumina and MyOme Strike Collaboration Deal Including Strategic Investment to Support MyOme's Clinical Trial That Could Save U.S. Healthcare $200 Billion Annually

Partnership unites Illumina's leading sequencing technology with cutting-edge clinical genomics analyses and AI to advance precision medicine for early detection and prevention.

ILMN : 134.95 (-0.27%)
The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know

ILMN : 134.95 (-0.27%)
AMPH : 27.12 (+1.16%)
ENSG : 176.44 (-0.12%)
Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

Appoints Garret Hampton and Alan Sachs to the Board Appoints William Donnelly as Executive Chair of the Board and Jeffrey Elliott as Lead Independent Director

IDYA : 35.20 (-1.35%)
TROW : 104.75 (+0.07%)
EXAS : 101.57 (+0.03%)
ILMN : 134.95 (-0.27%)
TMO : 580.74 (+0.28%)
SERA : 3.52 (-2.22%)
IR : 81.28 (-0.36%)
MTD : 1,420.10 (+0.21%)
QTRX : 6.46 (-2.42%)
LIFE : 1.9000 (+2.70%)
3 Reasons to Sell ILMN and 1 Stock to Buy Instead

3 Reasons to Sell ILMN and 1 Stock to Buy Instead

ILMN : 134.95 (-0.27%)
3 Unpopular Stocks with Warning Signs

3 Unpopular Stocks with Warning Signs

PLXS : 154.22 (+0.14%)
ILMN : 134.95 (-0.27%)
HIMX : 8.35 (+1.09%)
1 Momentum Stock with Promising Prospects and 2 We Avoid

1 Momentum Stock with Promising Prospects and 2 We Avoid

TXG : 16.49 (-1.20%)
ILMN : 134.95 (-0.27%)
PH : 888.08 (+0.04%)
Illumina whole-genome sequencing provides greater insight into genetic signals behind common diseases--according to Nature study

Study shows that rare variants captured by Illumina WGS with DRAGENâ„¢ variant calling explain most of the "missing heritability" in complex human diseases and traits, including those related to blood...

ILMN : 134.95 (-0.27%)
Illumina To Webcast Upcoming Investor Conference

SAN DIEGO , Nov. 11, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) today announced that its executives will be speaking at the following investor conference:

ILMN : 134.95 (-0.27%)
Illumina® Protein Prep delivers groundbreaking precision in NGS proteomics for more than 40 customers, ranging from academic institutions to large national biobanks

Following global commercial launch in September, Illumina Protein Prep's "out of the box" solution drives extraordinary accessibility to proteomics for researchers, with over 40,000 samples processed

ILMN : 134.95 (-0.27%)
LAB : 1.3800 (-6.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Illumina Inc. is a life sciences company, which provides tools and integrated systems for analysis of genetic variation and function. Using its proprietary technologies, the company provides innovative sequencing and array-based solutions for genotyping, copy number variation analysis, methylation studies,...

See More

Key Turning Points

3rd Resistance Point 140.53
2nd Resistance Point 138.53
1st Resistance Point 136.93
Last Price 134.95
1st Support Level 133.32
2nd Support Level 131.32
3rd Support Level 129.72

See More

52-Week High 153.06
Last Price 134.95
Fibonacci 61.8% 120.83
Fibonacci 50% 110.88
Fibonacci 38.2% 100.93
52-Week Low 68.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar